That’s a huge fall, Capricor Therapeutics stock Falls 26% Following FDA Briefing Capricor Therapeutics (NASDAQ:CAPR) shares fell 40% Monday after the FDA posted briefing documents ahead of the company’s July 29 advisory committee meeting.The Cellular, Tissue,...
A private matter, Luxfer to be taken private by Wynnchurch Capital Luxfer Holdings PLC (NYSE: LXFR) has agreed to be acquired by affiliates of Wynnchurch Capital, L.P. in an all-cash transaction at $17.37 per ordinary share, the company announced.The offer price...
We can do it better, Meta’s new seller app directly competes with eBay Shares of eBay (NASDAQ: EBAY) fell 3.7% Friday morning as investors reacted to Meta’s launch of a dedicated Seller app for Facebook Marketplace. While Meta’s product rollout was public, the...
Seeking approval, MannKind stock jumps on FDA approval MannKind Corporation (NASDAQ: MNKD) shares rose 6% Friday morning after the company announced FDA approval of Furoscix ReadyFlow and a $50 million private placement.The FDA approved Furoscix ReadyFlow (furosemide...
Life after Kroger fallout, Albertsons tumbles on earnings miss and slashed guidance Albertsons Companies, Inc. (NYSE: ACI) reported first-quarter results that missed analyst expectations and significantly reduced its full-year outlook, citing pressure from softer...
